Role of Levamisole as Immunomodulant in Mouse Lymphoma Model

References

• Glynn J. P., Humphreys R., Trivers G., Bianco A. R., Goldin A. Studies on Immunity to Leukemia L1210 in Mice. Cancer Res. 1963; 23: 1008
   PubMed Web of Science ®Google Scholar
• Ferrer J. F., Mihich E. Dependence of Regression of Sarcoma 180 in Vitamin B6-deficient Mice upon the Immunologic Competence of the Host. Cancer Res. 1967; 27: 456
   PubMedGoogle Scholar
• Mihich E. Combined Effects of Chemotherapy and Immunity against Leukemia L1210 in DBA/2 Mice. Cancer Res. 1969; 29: 848
   PubMed Web of Science ®Google Scholar
• Bonmassar E., Cudkowicz G., Vadlamudi S., Goldin A. Influence of Tumor-Host Differences at a Single Histocompatibility Locus(H-1) on the Antileukemic Effect of 1, 3-Bis(2-chloroethyl)-1-nitrosourea(NSC 409962). Cancer Res. 1970; 30: 2538
   PubMed Web of Science ®Google Scholar
• Riccardi C., Bartocci A., Puccetti P., Spreafico F., Bonmassar E., Goldin A. Combined Effects of Antineoplastic Agents and Anti-Lymphoma Allograft Reactions. Eur. J. Cancer 1980; 16: 23
   Web of Science ®Google Scholar
• Schultz R. M., Papamatheakis J. D., Luetzeles J., Chirigos M. A. Association of macrophage activation with antitumor activity by synthetic and biological agents. Cancer Res. 1977; 37: 3338
   PubMedGoogle Scholar
• Mathe' G., Kamel M., Dezfulian M., Halle-Pannenko O., Bourut G. An experimental screening for “systemic adjuvants of immunity” applicable in cancer immunotherapy. Cancer Res. 1973; 33: 1987
   PubMedGoogle Scholar
• Papa M. Z., Mule J. J., Rosenberg S. A. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: Successful immunotherapy of established pulmonary metastases from weakly and non-immunogenic murine tumors of three distinct histologic types. Cancer Res. 1986; 46: 4973
   PubMed Web of Science ®Google Scholar
• Herbermann R. B. Interferon and cytotoxic effector cells. Interferon, interferons and the immune system, J. Vileak, E. De Malyer. Elsevier Sci. Publ., Amsterdam 1984; 61
   Google Scholar
• Ophir R., Pecht M., HalFerin D., Rashid G., Burstein Y., Ben-Efraim S., Trainin N. THF-gamma 2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytoma. Cancer Immunol. Immunother. 1989; 30: 119
   PubMed Web of Science ®Google Scholar
• Favalli C., Mastino A., Jezzi T., Grelli S., Goldstein A. L., Garaci E. Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice. Int.J. Immunopharmacol. 1989; 11: 443
   PubMed Web of Science ®Google Scholar
• Bistoni F., Marconi P., Pitzurra M., Frati L., Spreafico F., Goldin A., Bonmassar E. Combined Effects of BCG or Candida albicans (CA) with Antitumor Agents against a Virus-Induced Lymphoma in Mice. Europ. J. Cancer 1979; 15: 1305
   Google Scholar
• Cassone A., Marconi P., Bistoni F., Mattia E., Sbaraglia G., Garaci E., Bonmassar E. Immunoadjuvant Effects of Candida albicans and its Cell Wall Fractions in a Mouse Lymphoma Model. Cancer Immunol. Immunother. 1981; 10: 181
   Google Scholar
• Renoux G., Renoux M., Teller M. N., McMahon S., Guillaumin J. M. Potentiation of T-cell mediated immunity by levamisole. Clin. Exp. Immunol. 1976; 25: 288
   PubMed Web of Science ®Google Scholar
• Hadden J. W., Englard A., Sadlik J. R., Hadden E. M. The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro. Int. J. Immunopharm. 1979; 1: 17
   PubMedGoogle Scholar
• Tripodi D., Parks L. C., Brugnans J. Drug-induced restoration of cutaneous hypersensibility in anergic patients with cancer. N. Engl. J. Med. 1973; 289: 354
   PubMed Web of Science ®Google Scholar
• Moertel C. G., Fleming T. R., Macdonald J. S., Haller D. G., Laurie J. A., Goodman P. J., Ungerleider J. S., Emerson W. A., Tormey D. C., Glick J. H. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 1990; 322: 352
   PubMed Web of Science ®Google Scholar
• Hamilton J. M., Sznol M., Friedman M. A. 5-Fluorouracil Plus Levamisole: Effective Adjuvant Treatment for Colon Cancer. Important Advances in Oncology 1990, V. T. De Vita, Jr., S. Hellman, S. A. Rosenberg, 1990; 115
   Google Scholar
• Laurie J. A., Moertel C. G., Fleming T. R., Wieand H. S., Leigh J. E., Rubin J., McCormack G. W., Gerstner J. B., Krook J. E., Malliard J. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. the North Central Cancer Treatment. Group and the Mayo Clinic. J. Clin. Oncol. 1989; 7: 1447
   PubMed Web of Science ®Google Scholar
• Iorio A. M., Barzi P., Rivosecchi-Merletti P., Goldin A., Bonmassar E. A Viral Immunodepressive Factor Associated with Experimental Mouse Tumors. Cancer Res. 1976; 36: 3851
   PubMedGoogle Scholar
• Giampietri A., Bonmassar E., Goldin A. Drug induced modulation of immune responses in mice: effects of 5–(3, 3 '-Dimethyl-l-triazeno)-imidadole-4-carboxamide (DTIC) and cyclophosphamide (Cy). J. Immunopharm. 1979; 1: 61
   Google Scholar
• Porschen R., Stremmel W. Adjuvante chemotherapie verbessert die uberlebenschancen beim kurativ operierten kolon-karzinom in studium Duke's C. Z. Gastroenterol. 1990; 28: 375
   PubMedGoogle Scholar
• Grem J. L. Levamisole as a therapeutic agent for colorectal carcinoma. Cancer Cells 1990; 2: 131
   PubMedGoogle Scholar
• Chirigos M. A., Pearson J. W., Pryor J. Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant. Cancer Res. 1973; 33: 2615
   PubMedGoogle Scholar
• Chirigos M. A., Fuhrman F., Pryor J. Prolongation of Chemotherapeutically Induced Remission of a Syngeneic Murine Leukemia by L-2, 3, 5, 6-Tetrahydro-6-phenylimidazo [2, 1-b] thiazole Hydrochloride. Cancer Res. 1975; 35: 927
   PubMedGoogle Scholar
• Perk K., Chirigos M. A., Fuhrman F., Pettigrew H. Brief Communication, Some Aspects of Host Response to Levamisole After Chemotherapy in a Murine Leukemia. J. Natl. Cancer Inst. 1975; 54: 253
   PubMedGoogle Scholar
• Johnson R. K, Houchens D. P., Gaston M. R., Goldin A. Effects of Levamisole (NSC-177023) and Tetramisole (NSC-102063) in Experimental Tumor Sistems. Cancer Chemotherapy Rep. 1975; 59: 697
   PubMedGoogle Scholar
• Sampson D., Peters T. G., Lewis J. D., Metzig J., Kurtz B. E. Dose dependence of immunopotentiation and tumor regression induced by levamisole. Cancer Res. 1977; 37: 3526
   PubMedGoogle Scholar
• Cassone A., Marconi P., Bistoni F., Mattia E., Sbaraglia G., Bonmassar E., Garaci E. Immunoadjuvant effects of “Candida albicans” and its Cell Wall fractions in a mouse lymphoma model. Cancer Immunol. Immunother. 1981; 10: 181
   Google Scholar
• Marconi P., Bistoni F., Cassone A., Frati L., Baccarini M., Garaci E., Bonmassar E. The role of the peritoneal cavity in successful treatment of a murine lymphoma with chemotherapy and non-specific immunostimulation. Cancer Immunol. Immunother. 1982; 13: 128
   PubMedGoogle Scholar
• Marconi P., Cassone A., Tissi L., Baccarini M., Puccetti P., Garaci E., Bonmassar E., Bistoni F. Cellular mechanisms underlying the adjuvant activity of Candida Albicans in a mouse lymphoma model. Int. J. Cancer 1982; 29: 483
   PubMedGoogle Scholar
• Mitchell M. S., Wade M. E., Deconti R. C., Bertino J. R., Calabresi P. Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann. Intern. Med. 1969; 70: 535
   PubMed Web of Science ®Google Scholar
• Tentori L., Leonetti C., Lanzilli G., Bonmassar E. IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5–(3, 3 Dimethil-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitro. Int.J. Immunopharm. 1990; 12: 831
   PubMedGoogle Scholar
• Miller R. A. Age associated decline in precursor frequency for different T cell mediated reactions, with preservation of helper or cytotoxic effect for precursor cell. J. Immunol. 1984; 132: 63
   PubMedGoogle Scholar
• Doria G., Adorini L., Mancini C., Frasca D. Modulation of Regulatory T Cell Functions in Aging. Advances in Immunomodulation, B. Bizzini, E. Bonmassar. Pythagora Press, Roma-Milan 1988; 181
   Google Scholar
• Hadden J. W., Hadden E. M. Therapy of secondary T-cell immunodeficiencies with biological substances and drug. Med. Oncol. Tumor Pharmacother. 1989; 6: 11
   PubMedGoogle Scholar
• Zatz M. M., Low T. L.K., Goldstein A. L. Role of Thymosin and other thymic hormones in T-cell differentiation. Biological Responses in Cancer, E. Mihic. Plenum Publishing Corporation, New York 1982
   Google Scholar
• Bonmassar E., Bonmassar A., Goldin A., Cudkowicz G. Depression of antilymphoma allograft reactivity by tumor-associated factors. Cancer Res. 1973; 33: 1056
   Google Scholar
• Isakov N., Segal S. A tumor-associated lactic dehydrogenase virus suppresses the host resistance to infection with Listeria monocytogenes. Immunobiol. 1983; 164: 402
   PubMedGoogle Scholar
• Onyekaba C. O., Harty J. T., Plageman P. G. Extensive cytocidal replication of lactate dehydrogenase-elevating virus in cultured peritoneal macrophages from 1–2 week old mice. Virus Res. 1989; 14: 327
   PubMedGoogle Scholar
• Fitzmaurice M. A. Physiological relationships among stress, viruses and cancer in experimental animals. Int. J. Neurosci. 1988; 39: 307
   PubMed Web of Science ®Google Scholar
• Cafruny W. A., Hovinen D. E. Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies. J. Gen. Virol. 1988; 69: 723
   PubMed Web of Science ®Google Scholar
• Obiri N. I., Dupere S. L., Pruett S. B., Lackey A., Emma D., O'Connor T. E. Levamisole meets sulfhydryl requirements of CTLL-2 cells and mediates enhanced proliferative response to mitogen stimulation without increasing interleukin-2 production. J. Biol. Resp. Mod. 1990; 9: 288
   PubMedGoogle Scholar
• Pinto A., Sorrentino R., Sorrentino L. Levamisole inhibits in vivo rat platelet aggregation by a release of prost. acyclin-like factor. Gen. Pharmacol. 1990; 21: 255
   PubMedGoogle Scholar
• Schwalke M. A., Tzanakakis G. N., Vezeridis M. P. Effects of prostacyclin on hepatic metastases from human pancreatic cancer in the nude mouse. J. Surg. Res. 1990; 49: 164
   PubMedGoogle Scholar
• Tzanakakis G. N., Agarwal K. C., Vezeridis M. P. Inhibition of hepatic metastasis from a human pancreatic adenocarcinoma(RWP-2) in the nude mouse by prostacyclin, forskolin, and ketoconazole. Cancer 1990; 65: 446
   PubMed Web of Science ®Google Scholar
• Thomas J. T., Boot-Handford R. P., Grant M. E. Modulation of type X collagen gene expression by calcium beta-glycerophosphate and levamisole: implications for a possible role for type X collagen in endochnodral bone formation. J. Cell. Sci. 1990; 95: 639
   PubMed Web of Science ®Google Scholar
• Takishita Y., Hiraiwa K., Nagayama M. Effect of retinoic acid on proliferation and differentiation of cultured chondrocytes in terminal differentiation. J. Biochem. 1990; 107: 592
   PubMedGoogle Scholar
• Chelberg M. K., McCarthy J. B., Skubitz A. P., Furcht L. T., Tsilibary E. C. Characterization of a synthetic peptide from type IV collagen that promotes melanoma cell adhesion, spreading, and motility. J. Cell. Biol. 1990; 111: 261
   PubMed Web of Science ®Google Scholar